Location: Home
  • search
  • go
  • Relate News
  • 7/31/2023NHSA Publishes 2022 National Basic Medical Insurance Sector Developmen...
  • 7/28/2023NHSA, MOF and SAT Jointly Issues the Notice on the Implementation of B...
  • 7/28/2023WuXi Vaccines' First Chinese Drug Substance Facility Released for GMP ...
  • 7/28/2023Recent Official and Executive Moves
  • 7/27/2023Roche Reports Strong Base Business Growth in H1, Drug Sales in China R...
  • 7/27/2023Kedrion to Supply Human Albumin in China following NIFDC Release
  • 7/26/2023Pharmaniaga, CSPC Sign MoU over Pharmaceutical Innovation
  • 7/26/2023When Multinationals Start De-risking, How Will Beijing Know? (Rhodium ...
  • 7/26/2023China's Licensing Market So Far This Year: Quarterly Highlights Show G...
  • 7/25/2023CDE Issues the Technical Guidelines for Preparation and Research of Ne...
  • 7/24/2023China Issues Policy Document on Major Healthcare Reform Tasks for the ...
  • 7/24/2023Big Pharma Bets Big on China (WSJ)
  • 7/21/2023NME Approvals Grew by 39% Year on Year in H1 2023 (PharmaDJ)
  • 7/21/2023NMPA Holds the 2023 National Drug Regulatory Work Symposium
  • 7/21/2023NHSA Issues the Rules for Contract Renewal of Negotiated Drugs and the...
  • 7/21/2023Recent Executive Moves
  • 7/20/2023Biotheus Enters Strategic Research and License Pact with BioNTech
  • 7/20/2023Sanofi Remains Bullish on China's Prospects with Plans to Launch More ...
  • 7/19/2023NHC Issues the Guiding Opinions for Advancing Clinical Specialty Capac...
  • 7/19/2023Chinese Hospital Drug Market Rebounded Sharply in Q1/2023: Sinohealth
  • 7/17/2023WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturin...
  • 7/17/2023NMPA Announces Additional Professional Journal Approved for Rx Drug Ad...
  • 7/17/2023NMPA Solicits Comments on the Technical Guidelines for Clinical Resear...
  • 7/17/2023China's Pharma Financing Slump Continued in H1 (PharmaDJ)
  • 7/14/2023Bayer to Launch More Innovative Drugs in China
  • 7/14/2023Review of Chinese Retail Pharmacy Sales 2013-2022
  • 7/14/2023Snapshot of Import Drugs Approved by NMPA in 2022 (2)
  • 7/14/2023PhIIC: Review of Chinese Hospital Drug Market in Q1/2023
  • 7/14/2023Recent Executive Moves
  • 7/12/2023BeiGene Announces FDA Acceptance of sNDA for Fifth BRUKINSA Indication
  • Page:48/360 Total number of articles:10791: [First][<<] [46] [47] [48] [49] [50] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group